Biotech Business Week

Glaucoma - Marketing agreement signed for ophthalmology device

Graft Failure - Enrollment completed for pivotal phase III trial studying E2F Decoy

HIV/AIDS Diagnostics - Letter of intent received for $4M purchase of HIV tests

HIV/AIDS Therapy - Viramune or Efavirenz regimens demonstrate comparable viral decay rate

Hematopoietic Cells - Lab company says cancer diagnostic system has received FDA approval

Hormone Replacement Therapy - Supplement can help relieve menopausal symptoms

Hypertension - ALT-711 clinical development outlined

IVD Compliance - Global alliance created among IVD medical device manufacturers

Immunology - Antibodies help pediatric diabetic patients reduce daily insulin dose

Infection - Anti-infective drugs highlighted at 43rd ICAAC

Infection Control - Antimicrobial biodegradable coating to reduce device infection risk

Information Technology - AstraZeneca deploys j-forceNET sales channel

Information Technology - Medication safety system added to AmeriNet agreement

Infusion Services - Pact signed for full-line dual-source infusion contract

Initial Public Offering - Eye-focused pharmaceutical files IPO registration statement

Laboratory Automation - Production under way for PatchXpress drug-screening platforms

Legal Issues - New patent covers restoring normal function to mutant proteins

Legal Issues - U.S. patent issued for high throughput gene expression analysis

Leukemia - European phase II study commences in pediatric acute lymphoblastic leukemia

Liquid Handling - FDA issues four patents on applications of acoustic droplet ejection

Listeria - System adopted as official method for detecting Listeria monocytogenes

Lung Cancer - Phase I trial initiated for lung cancer vaccine

Market Analysis - $20B growth factors market to expand in size, scope

Market Analysis - Average preclinical market research budgets 28% higher than phase I spending

Market Analysis - Current status reported for phase III trials of agents in oncology

Market Analysis - Drug market for type 2 diabetes will reach $20.5B in 2012

Marketing - I-Flow Corp. to copromote ON-Q Post-Surgical Pain Relief System

Medication Safety - Physicians encouraged to report adverse drug reactions in children

Mergers and Acquisitions - Cephalon's revised acquisition proposal reviewed

Mergers and Acquisitions - Genzyme completes acquisition

Mergers and Acquisitions - Maxxim Medical agrees to be acquired by equity firm

Mergers and Acquisitions - Peptide suppler acquires reagents maker

Mergers and Acquisitions - Regulatory approval received for Instrumentarium acquisition

Microarray - MWG Biotech strengthens U.S. market presence with partnerships

Multiple Sclerosis - New oral MS drug successfully passes phase II

Myocardial Infarction - Adjunctive therapy helps minimize damage to the heart

Myocardial Infarction - CORAL LAKE registry results presented

Myocardial Infarction - Study launched to identify patients in urgent need of defibrillators

Nausea - Aloxi now commercially availability

Nephropathy - Company announces first S.O.A.R. Program collaboration for KRX-101

Nutrition - Healthy meal planning guides offered for people with HIV using Viracept

OTC Trading - Biopharmaceutical company's stock can now be traded electronically

Oral Contraceptives - Generic Loestrin Fe 1/20 and 1.5/30 tablets approved

Otitis Media - Augmentin ES-600 more effective than Zithromax

Ovarian Cancer - NIH grant to be used for dendritic cell vaccine research

Pain Therapy - New palm-sized device manages spinal cord stimulation therapy

Patents - European patent granted for chemical genetics technology for kinase drug discovery

Patents - Patent granted for non-contact method for pico-to-nano volume fluid transfer

Patient Safety - Association aggressively seeking ways to improve patient safety

Personnel - Aesthetics group names board of directors

Personnel - Biotech company adds business, scientific leaders to its board of directors

Personnel - Biotech company forms scientific advisory board for potential cancer drug

Personnel - Biotech firm announces chairmanship transition

Personnel - Ettouati named chief business officer at oncology company

Personnel - New members named to board of directors at medical device firm

Personnel - Scientific advisory board appointment announced by pharmaceutical firm

Personnel - Sullivan elected to board of directors

Physiogenomics - New company will apply genomics to disease prevention

Predictive Gene Function - Use of proteomics solutions demonstrated in cardiovascular disease

Product Development - Medical product development company has new service offering

Prostate Cancer - Preliminary data from completed Provenge phase III trial D9901 reported

Pseudobulbar Affect - Data presented on late-stage drug candidate Neurodex

RNA Interference - Research collaboration studies effects of siRNA-induced gene silencing

Restenosis - Positive phase II results in restenosis trial of Neugene

Restenosis - Results presented on CDS-TC-32 in inhibition of restenosis

Rheumatoid Arthritis - Treatment receives notice of allowance for patent

SARS - Positive results reported from study of a new SARS ELISA kit

Stroke - Cranberry component linked to reduced stroke damage

Stroke - Data on novel targets, compounds for stroke therapy presented

Ventilator-Associated Pneumonia - Belfast research suggests way of reducing pneumonia in ITU patients

Wound Healing - Exclusive license acquired to market Hyper-O2/p